Lamivudine Teva Pharma B.V. 150 mg film-coated tablets
- Licence status
- Active substances
- Lamivudine
- Dosage Form
- Film-coated tablet
- Licence number
- EU/1/09/596/1-7
- Licence holder
- Teva Pharma B.V.
Product documents
Licence information
- ATC code
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors, J05AF05 lamivudine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 10/12/2009